• Panagiotis Zis, Vassiliki Brozou, Evmorfia Stavropoulou, Erifilli Argyra, Ioanna Siafaka, Evangelia Kararizou, Didier Bouhassira, Serge Perrot, Vassileios Zis, and Athina Vadalouca.
• Pain Relief and Palliative Care Unit, 1st Anaesthesiology Clinic, Aretaieion University Hospital, University of Athens, Athens, Greece.
• Pain Pract. 2017 Sep 1; 17 (7): 925-929.

Background And AimThe Fibromyalgia Rapid Screening Tool (FiRST) is a brief, simple, and straightforward self-administered questionnaire that was developed by Perrot et al. for the detection of fibromyalgia syndrome in patients with diffuse chronic pain. The aim of our study was to develop and validate the Greek version of FiRST.MethodsThe study was set up as a prospective observational study. The original French version of FiRST was adapted into Greek using forward and backward translation. Patients with chronic diffuse pain with a clinical diagnosis of fibromyalgia and osteoarthritis based on the criteria of the American College of Rheumatology were invited to participate to the study.ResultsOf the 101 patients who met our inclusion criteria, 42 were diagnosed with fibromyalgia and 59 with osteoarthritis. The 2 groups did not differ significantly regarding gender and pain characteristics (duration, intensity). Cronbach's alpha coefficient was 0.79. Receiver operating characteristic analysis showed an area under the curve of 89% (95% confidence interval = 83 to 95%; SE: 0.032, P < 0.001). At a cutoff score of ≥ 5, FiRST showed a sensitivity of 86%, a specificity of 83%, a positive predictive value of 78%, and a negative predictive value of 89%. The intraclass coefficient for the test-retest reliability was 0.96.ConclusionThe Greek version of FiRST is a valid screening tool for fibromyalgia in daily practice.© 2016 World Institute of Pain.

26 keywords...

hide…